These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 7668554)
1. Kinetics of the activation of the LIF-response factor in M1 myeloid leukemic cells. Piekorz RP; Bläsius R; Fey GH; Hocke GM Ann N Y Acad Sci; 1995 Jul; 762():452-4. PubMed ID: 7668554 [No Abstract] [Full Text] [Related]
2. Modulation of the activation status of Stat5a during LIF-induced differentiation of M1 myeloid leukemia cells. Piekorz RP; Rinke R; Gouilleux F; Neumann B; Groner B; Hocke GM Biochim Biophys Acta; 1998 Apr; 1402(3):313-23. PubMed ID: 9606990 [TBL] [Abstract][Full Text] [Related]
3. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a. Piekorz RP; Hocke GM Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012 [TBL] [Abstract][Full Text] [Related]
4. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells. Suzuki R; Sakamoto H; Yasukawa H; Masuhara M; Wakioka T; Sasaki A; Yuge K; Komiya S; Inoue A; Yoshimura A Oncogene; 1998 Oct; 17(17):2271-8. PubMed ID: 9811457 [TBL] [Abstract][Full Text] [Related]
6. Protein-tyrosine phosphatase PTPepsilon C inhibits Jak-STAT signaling and differentiation induced by interleukin-6 and leukemia inhibitory factor in M1 leukemia cells. Tanuma N; Nakamura K; Shima H; Kikuchi K J Biol Chem; 2000 Sep; 275(36):28216-21. PubMed ID: 10859312 [TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic domains of the leukemia inhibitory factor receptor required for STAT3 activation, differentiation, and growth arrest of myeloid leukemic cells. Tomida M; Heike T; Yokota T Blood; 1999 Mar; 93(6):1934-41. PubMed ID: 10068666 [TBL] [Abstract][Full Text] [Related]
8. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Minami M; Inoue M; Wei S; Takeda K; Matsumoto M; Kishimoto T; Akira S Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3963-6. PubMed ID: 8632998 [TBL] [Abstract][Full Text] [Related]
9. The pleiotropic actions of leukemia inhibitory factor. Gough NM; Williams RL Cancer Cells; 1989 Nov; 1(3):77-80. PubMed ID: 2518284 [TBL] [Abstract][Full Text] [Related]
11. The LIF-response element confers LIF-induced transcriptional control in P19 embryonal carcinoma cells. Hocke GM Ann N Y Acad Sci; 1995 Jul; 762():426-8. PubMed ID: 7545376 [No Abstract] [Full Text] [Related]
12. Interleukin-6 and leukemia inhibitory factor induction of JunB is regulated by distinct cell type-specific cis-acting elements. Sjin RM; Lord KA; Abdollahi A; Hoffman B; Liebermann DA J Biol Chem; 1999 Oct; 274(40):28697-707. PubMed ID: 10497240 [TBL] [Abstract][Full Text] [Related]
13. Members of the family of IL-6-type cytokines activate Stat5a in various cell types. Piekorz RP; Nemetz C; Hocke GM Biochem Biophys Res Commun; 1997 Jul; 236(2):438-43. PubMed ID: 9240457 [TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptors control competence to interpret leukemia inhibitory factor as an astrocyte inducer in developing cortex. Viti J; Feathers A; Phillips J; Lillien L J Neurosci; 2003 Apr; 23(8):3385-93. PubMed ID: 12716946 [TBL] [Abstract][Full Text] [Related]
16. Structural and functional studies on the leukemia inhibitory factor receptor (LIF-R): gene and soluble form of LIF-R, and cytoplasmic domain of LIF-R required for differentiation and growth arrest of myeloid leukemic cells. Tomida M Leuk Lymphoma; 2000 May; 37(5-6):517-25. PubMed ID: 11042511 [TBL] [Abstract][Full Text] [Related]
17. Alternative signaling mechanism of leukemia inhibitory factor responsiveness in a differentiating embryonal carcinoma cell. Takeda T; Kurachi H; Yamamoto T; Homma H; Adachi K; Morishige K; Miyake A; Murata Y Endocrinology; 1997 Jul; 138(7):2689-96. PubMed ID: 9202205 [TBL] [Abstract][Full Text] [Related]
18. Clonal variation in susceptibility to differentiation by different protein inducers in the myeloid leukemia cell line M1. Lotem J; Shabo Y; Sachs L Leukemia; 1989 Nov; 3(11):804-7. PubMed ID: 2509827 [TBL] [Abstract][Full Text] [Related]
19. Prolongation by differentiation-stimulating factor/leukemia inhibitory factor of the survival time of mice implanted with mouse myeloid leukemia cells. Yamamoto-Yamaguchi Y; Tomida M; Hozumi M Leuk Res; 1992 Oct; 16(10):1025-9. PubMed ID: 1405704 [TBL] [Abstract][Full Text] [Related]